Adagloxad Simolenin (OBI-822)

adagloxad simolenin · OBI Pharma, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Adagloxad Simolenin (OBI-822), covering 2025-05-09 to 2025-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC [Phase 3]

See pricing